Tong Guo
Director/Board Member at CHINA HEALTH GROUP INC.
Profile
Tong Guo is an Independent Non-Executive Director at China Health Group, Inc. and Cali Biosciences Co. Ltd.
He was previously the Chief Executive Officer at Gem Flower Pharmaceutical Science & Tech Beijing Co. Ltd., Vice President at IQVIA RDS (Shanghai) Co. Ltd., and Vice President-Clinical Information at Wuxi Cds Clinical Research Shanghai Co. Ltd.
Dr. Guo holds a doctorate degree from McGill University, which he received in 2009.
Tong Guo active positions
| Companies | Position | Start |
|---|---|---|
| CHINA HEALTH GROUP INC. | Director/Board Member | 2023-04-13 |
Cali Biosciences Co. Ltd.
 Cali Biosciences Co. Ltd. BiotechnologyHealth Technology Cali Biosciences Co. Ltd. operates as a biotechnology company dedicated to the research and development of new drugs for the perioperative space based on drug delivery platforms and other patented technologies. Its product focuses on non-opioid post-operative pain management, anti-inflammatory pain control, anesthesia, and sedation. The company was founded by Dibang Lin and Andrew Xian Chen on March 17, 2021 and is headquartered in Shenzhen, China. | Director/Board Member | - |
Former positions of Tong Guo
| Companies | Position | End |
|---|---|---|
| Gem Flower Pharmaceutical Science & Tech Beijing Co. Ltd. | Chief Executive Officer | 2021-02-28 |
| IQVIA RDS (Shanghai) Co. Ltd. | Corporate Officer/Principal | 2019-08-31 |
| Wuxi Cds Clinical Research Shanghai Co. Ltd. | Corporate Officer/Principal | 2015-03-31 |
Training of Tong Guo
| McGill University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CHINA HEALTH GROUP INC. | Health Technology |
| Private companies | 4 |
|---|---|
| IQVIA RDS (Shanghai) Co. Ltd. | |
Cali Biosciences Co. Ltd.
Cali Biosciences Co. Ltd. BiotechnologyHealth Technology Cali Biosciences Co. Ltd. operates as a biotechnology company dedicated to the research and development of new drugs for the perioperative space based on drug delivery platforms and other patented technologies. Its product focuses on non-opioid post-operative pain management, anti-inflammatory pain control, anesthesia, and sedation. The company was founded by Dibang Lin and Andrew Xian Chen on March 17, 2021 and is headquartered in Shenzhen, China. | Health Technology |
| Wuxi Cds Clinical Research Shanghai Co. Ltd. | |
| Gem Flower Pharmaceutical Science & Tech Beijing Co. Ltd. |
- Stock Market
- Insiders
- Tong Guo